Serina Therapeutics Inc (SER) earnings · rev $130.0K
These earnings events as JSON? API free 100/daySerina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
This SER earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SER revenue for 2025-12-31 was $130.0K. Net income was -$19.2M. Revenue was down 8.5% from 2023-12-31 to 2025-12-31. SER currently screens at market cap $29.7M.
When the next SER 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 8.5% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SER research stays on the stock page; the tape stays on the quote page.
SER earnings FAQ
What are SER's latest revenue and net income?
Latest cached Serina Therapeutics Inc (SER) revenue for Dec 31, 2025 was $130.0K. Net income was -$19.2M. Statements: https://lician.com/financials/ser
What is SER's latest diluted EPS?
Latest cached Serina Therapeutics Inc (SER) diluted EPS for Dec 31, 2025 was -$1.91.
What period does the latest SER earnings print cover?
The latest cached Serina Therapeutics Inc (SER) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.
How did SER revenue change from the prior cached period?
Cached Serina Therapeutics Inc (SER) revenue was down 8.5% from $142.0K (Dec 31, 2023) to $130.0K (Dec 31, 2025). Statements: https://lician.com/financials/ser
Where are SER earnings listed?
Cached earnings facts for Serina Therapeutics Inc (SER) are listed at https://lician.com/earnings/ser. Statements: https://lician.com/financials/ser
Not investment advice.